BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 32663576)

  • 1. Targeted delivery of lacosamide-conjugated gold nanoparticles into the brain in temporal lobe epilepsy in rats.
    Ugur Yilmaz C; Emik S; Orhan N; Temizyurek A; Atis M; Akcan U; Khodadust R; Arican N; Kucuk M; Gurses C; Ahishali B; Kaya M
    Life Sci; 2020 Sep; 257():118081. PubMed ID: 32663576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood-brain barrier targeted delivery of lacosamide-conjugated gold nanoparticles: Improving outcomes in absence seizures.
    Temizyürek A; Yılmaz CU; Emik S; Akcan U; Atış M; Orhan N; Arıcan N; Ahishali B; Tüzün E; Küçük M; Gürses C; Kaya M
    Epilepsy Res; 2022 Aug; 184():106939. PubMed ID: 35785634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lacosamide modulates interictal spiking and high-frequency oscillations in a model of mesial temporal lobe epilepsy.
    Behr C; Lévesque M; Ragsdale D; Avoli M
    Epilepsy Res; 2015 Sep; 115():8-16. PubMed ID: 26220372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Lacosamide Treatment on Epileptogenesis, Neuronal Damage and Behavioral Comorbidities in a Rat Model of Temporal Lobe Epilepsy.
    Shishmanova-Doseva M; Atanasova D; Uzunova Y; Yoanidu L; Peychev L; Marinov P; Tchekalarova J
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic treatment with the new anticonvulsant drug lacosamide impairs learning and memory processes in rats: A possible role of BDNF/TrkB ligand receptor system.
    Shishmanova-Doseva M; Peychev L; Koeva Y; Terzieva D; Georgieva K; Peychev Z
    Pharmacol Biochem Behav; 2018 Jun; 169():1-9. PubMed ID: 29605232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of lacosamide and controlled-release carbamazepine monotherapy in patients with newly diagnosed temporal lobe epilepsy: Post hoc analysis of a randomized, double-blind trial.
    Terada K; Kubota Y; Dimova S; Elmoufti S; Floricel F; Chellun D; O'Brien TJ
    Seizure; 2023 Nov; 112():62-67. PubMed ID: 37769545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lacosamide in patients with temporal lobe epilepsy: An observational multicentric open-label study.
    Borzì G; Di Gennaro G; Schmitt FC; D'Aniello A; Mumoli L; Zummo L; Daniele O; Russo E; Gambardella A; Labate A
    Epilepsy Behav; 2016 May; 58():111-4. PubMed ID: 27064831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lacosamide on background eeg activity in brain tumor-related epilepsy patients: A case series study.
    Maschio M; Zarabla A; Maialetti A; Sperati F; Dinapoli L; Dispenza S; Petreri G; Cantelmi T
    Brain Behav; 2018 Nov; 8(11):e01067. PubMed ID: 30334378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel action of lacosamide on GABA
    Ruffolo G; Di Bonaventura C; Cifelli P; Roseti C; Fattouch J; Morano A; Limatola C; Aronica E; Palma E; Giallonardo AT
    Neurobiol Dis; 2018 Jul; 115():59-68. PubMed ID: 29621596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of Dose and Antiepileptic Comedication on Lacosamide Serum Concentrations in Patients With Epilepsy of Different Ages.
    May TW; Helmer R; Bien CG; Brandt C
    Ther Drug Monit; 2018 Oct; 40(5):620-627. PubMed ID: 30086089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of life, mood and seizure control in patients with brain tumor related epilepsy treated with lacosamide as add-on therapy: A prospective explorative study with a historical control group.
    Maschio M; Zarabla A; Maialetti A; Fabi A; Vidiri A; Villani V; Giannarelli D
    Epilepsy Behav; 2017 Aug; 73():83-89. PubMed ID: 28623754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effect of Chronic Treatment with Lacosamide and Topiramate on Cognitive Functions and Impaired Emotional Responses in a Pilocarpine-induced Post-status Epilepticus Rat Model.
    Shishmanova-Doseva M; Tchekalarova J; Nenchovska Z; Ivanova N; Georgieva K; Peychev L
    Folia Med (Plovdiv); 2020 Dec; 62(4):723-729. PubMed ID: 33415916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic effects of Lacosamide in a rat model of traumatic brain injury: A histological, biochemical and electroencephalography monitoring study.
    Mete M; Alpay S; Aydemir I; Unsal UU; Collu F; Özel HF; Duransoy YK; Kutlu N; Tuglu Mİ
    Injury; 2021 Apr; 52(4):713-723. PubMed ID: 33714548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ictal heart rate increase precedes EEG discharge in drug-resistant mesial temporal lobe seizures.
    Di Gennaro G; Quarato PP; Sebastiano F; Esposito V; Onorati P; Grammaldo LG; Meldolesi GN; Mascia A; Falco C; Scoppetta C; Eusebi F; Manfredi M; Cantore G
    Clin Neurophysiol; 2004 May; 115(5):1169-77. PubMed ID: 15066542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticonvulsant effect of gentamicin on the seizures induced by kainic acid.
    Zhao Y; Wang Z; Lao W; Kuang P; Jiang N; Yin T; Lin W; Zhu H; Ji Y
    Neurol Res; 2018 Jan; 40(1):45-52. PubMed ID: 29088985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug resistance and hippocampal damage after delayed treatment of pilocarpine-induced epilepsy in the rat.
    Chakir A; Fabene PF; Ouazzani R; Bentivoglio M
    Brain Res Bull; 2006 Dec; 71(1-3):127-38. PubMed ID: 17113938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baicalein improves cognitive deficits and hippocampus impairments in temporal lobe epilepsy rats.
    Qian X; Wang ZR; Zheng JJ; Ding JQ; Zhong JG; Zhang TY; Li W; Zhang M
    Brain Res; 2019 Jul; 1714():111-118. PubMed ID: 30817901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous local intrahippocampal delivery of adenosine reduces seizure frequency in rats with spontaneous seizures.
    Van Dycke A; Raedt R; Dauwe I; Sante T; Wyckhuys T; Meurs A; Vonck K; Wadman W; Boon P
    Epilepsia; 2010 Sep; 51(9):1721-8. PubMed ID: 20726873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance to phenobarbital extends to phenytoin in a rat model of temporal lobe epilepsy.
    Bethmann K; Brandt C; Löscher W
    Epilepsia; 2007 Apr; 48(4):816-26. PubMed ID: 17319923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycine transporter 1 is a target for the treatment of epilepsy.
    Shen HY; van Vliet EA; Bright KA; Hanthorn M; Lytle NK; Gorter J; Aronica E; Boison D
    Neuropharmacology; 2015 Dec; 99():554-65. PubMed ID: 26302655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.